ACE1-I/D Polymorphism in Patients With Severe COVID-19

Author(s):
Fouzieh KarimiFouzieh Karimi1,*, Vahedeh HosseiniVahedeh Hosseini2, Abbas AhmadiAbbas Ahmadi2, Fahimeh Ranjbar KermaniFahimeh Ranjbar Kermani1, Shirin FerdowsiShirin Ferdowsi1
1Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran
2Cellular and Molecular Research Center, Research Institute for health development & Department of Molecular Medicine and Genetics, Faculty of Medicine, Kurdistan University of Medical Sciences, Sanandaj, Iran.

Journal of Cellular & Molecular Anesthesia:Vol. 8, issue 3; e149285
Published online:Feb 28, 2023
Article type:Research Article
How to Cite:Karimi F, Hosseini V, Ahmadi A, Kermani FR, Ferdowsi S. ACE1-I/D Polymorphism in Patients With Severe COVID-19. J Cell Mol Anesth. 2023;8(3):e149285. doi: https://doi.org/10.22037/jcma.v8i3.40994

Abstract

Similar Articles

31
Oct
2024
Jundishapur J Microbiol

A Multicentric Study of ACE2 rs2285666 Polymorphism: The Association with COVID-19 in the Iranian Population

Hadi Razavi Nikoo,
Seyed Majid Fatahi,
Mahdieh Taheri,
Mohammad Jamshidi,
Ali Safarzadeh,
Ashkan Alamdary
,et al.

Razavi Nikoo H, Fatahi SM, Taheri M, Jamshidi M, Safarzadeh A, et al. A Multicentric Study of ACE2 rs2285666 Polymorphism: The Association with COVID-19 in the Iranian Population. Jundishapur J Microbiol. 2024;17(10):e153765. doi: https://doi.org/10.5812/jjm-153765

19
Oct
2021

Effect Of Angiotensin-Converting Enzyme Inhibitors And Angiotensin Receptor Blockers On the Clinical Outcome In COVID-19 Patients With Hypertension

Zahra Fakhrae,
Saeid Bitaraf,
Roohangize Nashibi,
Fatemeh Ahmadi,
Safoura Khosravi,
Shokrollah Salmanzadeh

Fakhrae Z, Bitaraf S, Nashibi R, Ahmadi F, Khosravi S, et al. Effect Of Angiotensin-Converting Enzyme Inhibitors And Angiotensin Receptor Blockers On the Clinical Outcome In COVID-19 Patients With Hypertension. J Cell Mol Anesth. 2021;6(4):e149739. doi: https://doi.org/10.22037/jcma.v6i4.35596

19
Sep
2022
Trends in Med Sci

ACE2 in SARS-CoV-2-Mediated COVID-19: A Brief Review

Pooria Safarzadeh Kozani,
Setareh Dashti Shokoohi,
Narges Baharifar,
Sepideh Sheikhi,
Fatemeh Khalaf Shamsabadi,
Forough Chamaie Nejad
,et al.

Safarzadeh Kozani P, Dashti Shokoohi S, Baharifar N, Sheikhi S, Khalaf Shamsabadi F, et al. ACE2 in SARS-CoV-2-Mediated COVID-19: A Brief Review. J Adv Immunopharmacol. 2022;2(4):e130682. doi: https://doi.org/10.5812/tms-130682

24
Aug
2024
Arch Clin Infect Dis

Biochemical Risk Factors of Atherosclerosis in Patients with Severe and Non-severe COVID-19

Maryam Shahali,
Ashkan Alamdary,
Alireaza Gholami,
Rasul Moukhah,
Seyed Dawood Mousavi-Nasab,
Mohammad Javad Hossein Tehrani
,et al.

Shahali M, Alamdary A, Gholami A, Moukhah R, Mousavi-Nasab SD, et al. Biochemical Risk Factors of Atherosclerosis in Patients with Severe and Non-severe COVID-19. Arch Clin Infect Dis. 2024;19(4):e144661. doi: https://doi.org/10.5812/archcid-144661

20
Apr
2022
Ann Mil Health Sci Res

Evaluation of Mutation in Spike Gene of Covid-19 in Iranian Patients

Mohammad Gholami,
Negin Hosseini Rouzbahani,
Hamed Naghoosi,
Sajad Fani-Kheshti,
Seyyed-Javad Hosseini-Shokouh

Gholami M, Hosseini Rouzbahani N, Naghoosi H, Fani-Kheshti S, Hosseini-Shokouh S. Evaluation of Mutation in Spike Gene of Covid-19 in Iranian Patients. Ann Mil Health Sci Res. 2022;20(1):e123942. doi: https://doi.org/10.5812/amh-123942

Indexed in

Crossmark
Crossmark
Checking
Share on
Cited by
Metrics

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC 

Search Relations

Author(s):

Related Articles